SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-033943
Filing Date
2022-10-21
Accepted
2022-10-21 15:03:06
Documents
1
Period of Report
2022-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5930
  Complete submission text file 0000899243-22-033943.txt   7805
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Reporting) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36112 | Film No.: 221323211

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Issuer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ARA HILL TOP BUILDING, UNIT A-5 PLETTERIJWEG OOST 1, CURACAO WILLEMSTAD P8 000000
Business Address
BIOTECH TARGET N V (Reporting) CIK: 0001259870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36112 | Film No.: 221323212